 | Up a level |
Degenhardt, T., Gluz, O., Thomssen, C., Vetter, M., Kates, R., Warm, M., Shak, S., Augustin, D., Kusche, M., Untch, M., Paepke, S., Uleer, C., Duennebacke, J., Nitz, U. and Harbeck, N. (2010). Risk Group Selection in Primary Breast Cancer According to ASCO Recommended Biomarkers Onkotype DX and uPA/PAI-1: First Experience from Prospective Multicenter WSG Plan B Trial. Cancer Res., 70. PHILADELPHIA: AMER ASSOC CANCER RESEARCH. ISSN 1538-7445
Eichler, C., Baucks, C., Malter, W., Thangarajah, F., Puppe, J., Holtschmidt, J. and Warm, M. (2020). Platelet-rich plasma (PRP/ACP) in breast cancer patients Post-surgical complication rates and long term comparative analysis of the treatment 163 sentinel node biopsy patients. Geburtshilfe Frauenheilkd., 80 (10). S. E96 - 1. STUTTGART: GEORG THIEME VERLAG KG. ISSN 1438-8804
Eichler, C., Baucks, C., Malter, W., Thangarajah, F., Puppe, J., Holtschmidt, J. and Warm, M. (2020). Platelet-rich plasma (PRP/ACP) in breast cancer patients Post-surgical complication rates and long term comparative analysis of the treatment 163 sentinel node biopsy patients. Geburtshilfe Frauenheilkd., 80 (6). S. E28 - 1. STUTTGART: GEORG THIEME VERLAG KG. ISSN 1438-8804
Eichler, C., Baucks, C., Uener, J., Pahmeyer, C., Ratiu, D., Gruettner, B., Malter, W. and Warm, M. (2020). Platelet-Rich Plasma (PRP) in Breast Cancer Patients: An Application Analysis of 163 Sentinel Lymph Node Biopsies. Biomed Res. Int., 2020. LONDON: HINDAWI LTD. ISSN 2314-6141
Eichler, C., Najafpour, M., Sauerwald, A., Puppe, J. and Warm, M. (2015). Platelet-Rich Plasma in the Treatment of Subcutaneous Venous Access Device Scars: A Head-to-Head Patient Survey. Biomed Res. Int., 2015. LONDON: HINDAWI LTD. ISSN 2314-6141
Eichler, C., Vogt, N., Brunnert, K., Sauerwald, A., Puppe, J. and Warm, M. (2016). A head to head comparison between SurgiMend (R) - Fetal bovine acellular dermal matrix and Epiflex (R) - Decellularized human skin tissue in breast reconstruction in 127 cases. Cancer Res., 76. PHILADELPHIA: AMER ASSOC CANCER RESEARCH. ISSN 1538-7445
Eichler, C. and Warm, M. (2017). Neoadjuvant or not? Aspects of treatment planning after 20 years of neoadjuvant therapy. Gynakologe, 50 (7). S. 488 - 498. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1433-0393
Eichler, C., Westerhof, A., Warm, M., Puppe, J., Krug, B. and Malter, W. (2020). Improving breast conserving surgery using the Faxitron (TM) OR Specimen Radiography System - complication analysis, cost evaluation and literature review. Geburtshilfe Frauenheilkd., 80 (10). S. E96 - 1. STUTTGART: GEORG THIEME VERLAG KG. ISSN 1438-8804
Eichler, C., Westerhoff, A., Warm, M., Puppe, J., Krug, B. and Malter, W. (2020). Improving breast conserving surgery using the FaxitronT OR Specimen Radiography System - complication analysis, cost evaluation and literature review. Geburtshilfe Frauenheilkd., 80 (6). S. E28 - 2. STUTTGART: GEORG THIEME VERLAG KG. ISSN 1438-8804
Fasching, P. A., Jud, S. M., Hauschild, M., Kuemmel, S., Schuette, M., Warm, M., Hanf, V., Muth, M., Baler, M., Schulz-Wendtland, R., Beckmann, M. W. and Lux, M. P. (2012). Anticancer activity of letrozole plus zoledronic acid as neoadjuvant therapy for postmenopausal patients with breast cancer: FEMZONE trial results. Cancer Res., 72. PHILADELPHIA: AMER ASSOC CANCER RESEARCH. ISSN 1538-7445
Nabieva, N., Fehm, T., Haeberle, L., de Waal, J., Rezai, M., Baier, B., Baake, G., Kolberg, H. -C., Guggenberger, M., Warm, M., Harbeck, N., Wuerstlein, R., Deuker, J. -U., Dall, P., Richter, B., Wachsmann, G., Brucker, C., Siebers, J. W., Popovic, M., Kuhn, T., Wolf, C., Vollert, H. -W., Breitbach, G. -P., Janni, W., Landthaler, R., Kohls, A., Rezek, D., Noesselt, T., Fischer, G., Henschen, S., Praetz, T., Heyl, V., Kuehn, T., Krauss, T., Thomssen, C., Hohn, A., Tesch, H., Mundhenke, C., Hein, A., Hack, C. C., Schmidt, K., Belleville, E., Brucker, S. Y., Kuemmel, S., Beckmann, M. W., Wallwiener, D., Hadji, P. and Fasching, P. A. (2018). Influence of side-effects on early therapy persistence with letrozole in post-menopausal patients with early breast cancer: Results of the prospective EvAluate-TM study. Eur. J. Cancer, 96. S. 82 - 91. OXFORD: ELSEVIER SCI LTD. ISSN 1879-0852
Nabieva, N., Kellner, S., Fehm, T., Haebrle, L., de Waal, J., Rezai, M., Baier, B., Baake, G., Kolberg, H. -C., Guggenberger, M., Warm, M., Harbeck, N., Wuerstlein, R., Deuker, J. -U., Dall, P., Richter, B., Wachsmann, G., Brucker, C., Siebers, J. W., Fersis, N., Kuhn, T., Wolf, C., Vollert, H. -W., Breitbach, G. -P., Janni, W., Landthaler, R., Kohls, A., Rezek, D., Noesselt, T., Fischer, G., Henschen, S., Praetz, T., Heyl, V., Kuehn, T., Krauss, T., Thomssen, C., Hohn, A., Tesch, H., Mundhenke, C., Hein, A., Rauh, C., Bayer, C. M., Jacob, A., Schmidt, K., Belleville, E., Brucker, S. Y., Kuemmel, S., Beckmann, M. W., Wallwiener, D., Hadji, P. and Fasching, P. A. (2018). Influence of patient and tumor characteristics on early therapy persistence with letrozole in postmenopausal women with early breast cancer: results of the prospective Evaluate-TM study with 3941 patients. Ann. Oncol., 29 (1). S. 186 - 193. OXFORD: OXFORD UNIV PRESS. ISSN 1569-8041
Nitz, U., Gluz, O., Oberhoff, C., Reimer, T., Schumacher, C., Hackmann, J., Warm, M., Uleer, C., Runde, V., Kuemmel, S., Zuna, I. and Harbeck, N. (2011). Adjuvant Chemotherapy with or without Darbepoetin alpha in Node-Positive Breast Cancer: Survival and Quality of Life Analysis from the Prospective Randomized WSG ARA Plus Trial. Cancer Res., 71. PHILADELPHIA: AMER ASSOC CANCER RESEARCH. ISSN 1538-7445
Nitz, U., Gluz, O., Zuna, I., Oberhoff, C., Reimer, T., Schumacher, C., Hackmann, J., Warm, M., Uleer, C., Runde, V., Duennebacke, J., Belzl, N., Augustin, D., Kates, R. E. and Harbeck, N. (2014). Final results from the prospective phase III WSG-ARA trial: impact of adjuvant darbepoetin alfa on event-free survival in early breast cancer. Ann. Oncol., 25 (1). S. 75 - 82. OXFORD: OXFORD UNIV PRESS. ISSN 1569-8041
Nitz, Ulrike, Gluz, Oleg, Clemens, Michael, Malter, Wolfram, Reimer, Toralf, Nuding, Benno, Aktas, Bahriye, Stefek, Andrea, Pollmanns, Anke, Lorenz-Salehi, Fatemeh, Uleer, Christoph, Krabisch, Petra, Kuemmel, Sherko, Liedtke, Cornelia, Shak, Steven, Wuerstlein, Rachel, Christgen, Matthias, Kates, Ronald E., Kreipe, Hans H., Harbeck, Nadia, Ackermann, S., Aktas, B., Augustin, D., Baake, G., Baumann, K., Berger, R., Bettscheider, J., Bischoff, J., Clemens, M., Deryal, M., Dubbers, H., Duchting, D., Dunnebacke, J., Fett, W., Fietz, T., Fischer, H., Forner, M., Forstbauer, H., Freese, K., Geberth, M., Glados, M., Gnauert, K., Goette, O., Gohring, U., Goppinger, A., Grafe, A., Hackenberg, R., Hackmann, J., Hellriegel, M., Heyl, V., Hoestermann, C., Hoffmann, G., Hofmann, M., Hucke, J., Jackisch, C., Jungberg, P., Just, M., Kahl, C., Klare, P., Kogel, M., Kohls, A., Amrawy, B. Konigs-El, Konnecke, P., Krabisch, P., Kraudelt, S., Kremers, S., Kummel, S., Kurbacher, C., Kusche, J., Liedtke, B., Liedtke, C., Link, H., Lorenz, R., Salehi, F. Lorenz, Lubbe, K., Malter, W., Melekian, B., Mobus, V., Montenarh, M., Mueller, V., Mundhenke, C., Niederle, N., Nitz, U., Noesselt, T., Oberhoff, C., Paas, L., Paepke, S., Pollmanns, A., Reichert, D., Reimer, T., Romann, D., Ruhland, T., Runde, V., Salem, M., Schlosser, A., Schneider, A., Schrader, I., Schulz, H., Schumacher, C., Schwickerath, J., Soling, U., Stauder, H., Stefek, A., Steinmetz, T., Stickeler, E., Terhaag, J., Thomssen, C., Tome, O., Uleer, C., Warm, M., Wachsmann, G., Wacker, J., Wiebringhaus, H., Wiest, W., Wolfgarten, M., Nitz, U., Christgen, H., Kreipe, H., Buehne, C., Gluz, O., Hansen, K., Hofmann, D., Kates, R., Mangold, M., Mathissen, M., Raeth, P., Renner, I., Reiser, I., Schumacher, J., Staedele, M. and Walter-Kirst, R. (2019). West German Study PlanB Trial: Adjuvant Four Cycles of Epirubicin and Cyclophosphamide Plus Docetaxel Versus Six Cycles of Docetaxel and Cyclophosphamide in HER2-Negative Early Breast Cancer. J. Clin. Oncol., 37 (10). S. 799 - 811. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755
Sauerwald, A., Niggl, M., Puppe, J., Prescher, A., Scaal, M., Noe, G. K., Schiermeier, S., Warm, M. and Eichler, C. (2016). Laparoscopic Pectopexy: A Biomechanical Analysis. PLoS One, 11 (2). SAN FRANCISCO: PUBLIC LIBRARY SCIENCE. ISSN 1932-6203
Untch, M., Jackisch, C., Schneeweiss, A., Schmatloch, S., Aktas, B., Denkert, C., Schem, C., Wiebringhaus, H., Kuemmel, S., Rhiem, K., Warm, M., Fasching, P. A., Just, M., Hanusch, C., Hackmann, J., Blohmer, J-U., Furlanetto, J., Nekljudova, V., von Minckwitz, G. and Loibl, S. (2018). Impact of nab-paclitaxel dose reduction on survival of the randomized phase III GeparSepto trial comparing neoadjuvant chemotherapy of weekly nab-paclitaxel (nP) with solvent-based paclitaxel (P) followed by anthracycline/cyclophosphamide for patients with early breast cancer (BC). Ann. Oncol., 29. S. 60 - 61. OXFORD: OXFORD UNIV PRESS. ISSN 1569-8041
de Wit, M., Honecker, F., Wedding, U., Waldenmaier, D., Dorn, J., Warm, M., Al-Batran, S., Schmidt, M., Kreienberg, R., Jaeger, E., Saupe, S., Mueller, L., Burkhard, J. O. and Harbeck, N. (2010). Correlation Comprehensive Geriatric Assessment (CGA) and Inflammation and Nutrition Parameters with Outcome Measures in the Phase III PELICAN Trial for Metastatic Breast Cancer (MBC). Cancer Res., 70. PHILADELPHIA: AMER ASSOC CANCER RESEARCH. ISSN 1538-7445